Kyowa Kirin announced that its board of directors approved plans to invest up to $530 million to build a new pharmaceutical manufacturing facility. The Japan-based company plans to build a new, state-of-the-art facility in Sanford, North Carolina. It expects the 171,700-square-foot, two-reactor facility to accelerate the development and production of biologic therapies for rare and…